GGrantIndex
← Leaderboards

Mansoor Sarfarazi

University Of Connecticut Sch Of Med/Dnt

$8,504,234
Attributed
$8,504,234
Total exposure
6
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $834.6K · FY200510
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10

Funding mix

By agency

NIH$8,504,234 · 6

By mechanism

R01$8,456,335 · 4
M01$47,899 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Connecticut Sch Of Med/Dnt

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchGene MutationGlaucomaHuman Genetic Material TagHuman SubjectGenetic SusceptibilityFamily GeneticsGenotypeGenetic DisorderGenetic ScreeningLinkage MappingPolymerase Chain ReactionDenaturing Gradient Gel ElectrophoresisMolecular CloningSingle Strand Conformation PolymorphismMolecular GeneticsPhenotypeGenetic MarkersGenetic Disorder DiagnosisNucleic Acid SequenceCytochrome P450Gene ExpressionGlaucoma TestDiagnosis Design /Evaluation

Grant awards (37)

Molecular Genetics of Primary Congenital Glaucoma$558,333
R01 · FY2010 · EY · contact PI
Molecular Genetics of Primary Congenital Glaucoma$547,547
R01 · FY2009 · EY · contact PI
Molecular Genetics of Primary Congenital Glaucoma$520,970
R01 · FY2008 · EY · contact PI
Molecular Genetics of Primary Congenital Glaucoma$516,117
R01 · FY2007 · EY · contact PI
Functional Analysis of Optineurin in Glaucoma$316,800
R01 · FY2007 · EY · contact PI
Molecular Genetics of Primary Congenital Glaucoma$516,049
R01 · FY2006 · EY · contact PI
Functional Analysis of Optineurin in Glaucoma$318,584
R01 · FY2006 · EY · contact PI
Functional Analysis of Optineurin in Glaucoma$326,250
R01 · FY2005 · EY
MOLECULAR GENETICS OF CHRONIC OPEN-ANGLE GLAUCOMA$418,368
R01 · FY2004 · EY
MOLECULAR GENETICS OF PRIMARY COGENITAL GLAUCOMA$326,250
R01 · FY2004 · EY
Functional Analysis of Optineurin in Glaucoma$313,290
R01 · FY2004 · EY
Molecular Screening Methods for Different Types of Glaucoma$955
M01 · FY2004 · RR
MOLECULAR GENETICS OF CHRONIC OPEN-ANGLE GLAUCOMA$406,184
R01 · FY2003 · EY
MOLECULAR GENETICS OF PRIMARY COGENITAL GLAUCOMA$326,250
R01 · FY2003 · EY
MOLECULAR CHARACTERIZATION OF FAMILIAL LYMPHEDEMA$303,750
R01 · FY2003 · HL
MOLECULAR GENETICS OF CHRONIC OPEN-ANGLE GLAUCOMA$394,352
R01 · FY2002 · EY
MOLECULAR GENETICS OF PRIMARY COGENITAL GLAUCOMA$326,250
R01 · FY2002 · EY
MOLECULAR CHARACTERIZATION OF FAMILIAL LYMPHEDEMA$303,750
R01 · FY2002 · HL
MOLECULAR SCREENING METHODS FOR DIFFERENT TYPES OF GLAUCOMA$0
M01 · FY2002 · RR
POSITIONAL MAPPING OF PRIMARY CONGENITAL GLAUCOMA$0
M01 · FY2002 · RR
MOLECULAR GENETICS OF CHRONIC OPEN-ANGLE GLAUCOMA$382,863
R01 · FY2001 · EY
MOLECULAR GENETICS OF PRIMARY COGENITAL GLAUCOMA$326,250
R01 · FY2001 · EY
MOLECULAR CHARACTERIZATION OF FAMILIAL LYMPHEDEMA$313,167
R01 · FY2001 · HL
MOLECULAR SCREENING METHODS FOR DIFFERENT TYPES OF GLAUCOMA$4,361
M01 · FY2001 · RR
POSITIONAL MAPPING OF PRIMARY CONGENITAL GLAUCOMA$4,361
M01 · FY2001 · RR
POSITIONAL MAPPING OF PRIMARY CONGENITAL GLAUCOMA$0
M01 · FY2001 · RR
MOLECULAR SCREENING METHODS FOR DIFFERENT TYPES OF GLAUCOMA$0
M01 · FY2001 · RR
MOLECULAR SCREENING METHODS FOR DIFFERENT TYPES OF GLAUCOMA$0
M01 · FY2001 · RR
POSITIONAL MAPPING OF PRIMARY CONGENITAL GLAUCOMA$0
M01 · FY2001 · RR
MOLECULAR GENETICS OF CHRONIC OPEN-ANGLE GLAUCOMA$381,536
R01 · FY2000 · EY
MOLECULAR GENETICS OF PRIMARY COGENITAL GLAUCOMA$313,425
R01 · FY2000 · EY
POSITIONAL MAPPING OF PRIMARY CONGENITAL GLAUCOMA$19,111
M01 · FY2000 · RR
MOLECULAR SCREENING METHODS FOR DIFFERENT TYPES OF GLAUCOMA$19,111
M01 · FY2000 · RR
MOLECULAR SCREENING METHODS FOR DIFFERENT TYPES OF GLAUCOMA$0
M01 · FY2000 · RR
MOLECULAR SCREENING METHODS FOR DIFFERENT TYPES OF GLAUCOMA$0
M01 · FY2000 · RR
POSITIONAL MAPPING OF PRIMARY CONGENITAL GLAUCOMA$0
M01 · FY2000 · RR
POSITIONAL MAPPING OF PRIMARY CONGENITAL GLAUCOMA$0
M01 · FY2000 · RR